Skip to main content
TipRanks
Go Ultimate75% OFF

Mark Strobeck Insider Profile

4 Followers

Mark Strobeck, President & CEO, Director at Rockwell Med, holds 62.35K shares in Rockwell Med (Ticker: RMTI), holds 2.30K shares in Windtree Therapeutics (Ticker: WINT), holds 248.60K shares in Assertio Therapeutics (Ticker: ASRT).

Mark Strobeck's Trading History

RMTI
Rockwell Med
Jul 06, 2026President & CEO, DirectorUninformative Buy―$421.48K
WINT
Windtree Therapeutics
Aug 25, 2023DirectorUninformative Buy―$27.60
ASRT
Assertio Therapeutics
May 22, 2020―Uninformative Buy―$5.84M
ZCOR
Zyla Life Sciences
May 21, 2020―Uninformative Sell―$0.00
EGLTQ
Egalet Corp
Feb 04, 2019―Uninformative Sell―$0.00

You May Also Like

Mark Strobeck insider profile FAQ

What stocks does Mark Strobeck hold?
Mark Strobeck holds: RMTI, ASRT, EGLTQ, WINT, ZCOR stocks.
What is Mark Strobeck's role in Rockwell Med?
Mark Strobeck's role in Rockwell Med is President & CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.